← back to search

Xiaojie Si

Zhengzhou University · CN

Area of research

Organic Chemistry · Molecular Biology

Research interest

Research topics from publications: Annual review of KRAS inhibitors in 2022; The overview of Mitogen-activated extracellular signal-regulated kinase (MEK)-based dual inhibitor in the treatment of cancers.

h-index

—

citations

0

works

0

NIH funding

—

primary concept

—

email

✉ Find email ↗

Recent publications

Annual review of KRAS inhibitors in 2022

European Journal of Medicinal Chemistry 2023cited by 50position: middledoi

The overview of Mitogen-activated extracellular signal-regulated kinase (MEK)-based dual inhibitor in the treatment of cancers

Bioorganic & Medicinal Chemistry 2022cited by 13position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Fuqiang Yu · Zhengzhou University2 papers (2022–2023)Limin Liu · Soochow University2 papers (2022–2023)Hao Wang · Henan Cancer Hospital2 papers (2022–2023)Zhengjie Wang · Zhengzhou University2 papers (2022–2023)Lingling Chi · Zhengzhou University2 papers (2022–2023)Jiaxin Zheng · The First Affiliated Hospital, Sun Yat-sen University2 papers (2022–2023)Qiurong Zhang · Ministry of Education of the People's Republic of China2 papers (2022–2023)Chao Gao · Chinese Academy of Medical Sciences & Peking Union Medical College2 papers (2022–2023)Hong‐Min Liu · Ministry of Education1 papers (2022–2022)Lihong Shan · Ministry of Education of the People's Republic of China1 papers (2023–2023)Yu Ke · Ministry of Education1 papers (2022–2022)Hongling Dai · Zhengzhou University1 papers (2022–2022)— · 1 papers (2023–2023)Honglin Dai · Zhengzhou University1 papers (2023–2023)